08:00 , Feb 9, 2012 |  BC Innovations  |  Targets & Mechanisms

HUS and them

Two groups have identified new strategies to treat or prevent hemolytic uremic syndrome, a potentially lethal complication of Escherichia coli infection. A team at the University of Toronto has suggested that the marketed CXC chemokine...
08:00 , Jan 26, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Hematology

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Hematology Hemolytic uremic syndrome Golgi integral membrane protein 4 (GOLIM4; GPP130) In vitro and mouse studies suggest GPP130 inhibitors or Mn2+ could...